Orouboros mixed up [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2010-03-09 10:33 (5942 d 17:06 ago) – Posting: # 4882
Views: 31,322

Dear Helmut!

Oh, oh the orouboros has beaten again!

❝ ... But as a statistical amateur I don't get the point looking at the referred paper:

❝ Hsuan FC, Reeve R. Assessing individual bioequivalence with high-order cross-over designs: a unified procedure. Stat Med. 2003;22:2847–60.


I must confess that I had not understand this paper at all, thus being less than an amateur
("Blutiger Laie" = raw recruit :yes:).

❝ The method we proposed here has been implemented in a Pharsight™ product, WinNonlin® (version 3.2 or later).


Too bad I do not own WinNonlin.
Can you eventually show some output of this method?

What do you think about an adaption of

J.-P. Liu
Use of the repeated cross-over design in assessing bioequivalence
Statist. Med. 14, 1067-1078 (1995)

It has ANOVA tables but Liu term his model underlying the analysis "Mixed"!
Mixed effects for subject and subject*formulation interaction.
Without mixed effects the corresponding F-Tests would be others, I think.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
135 visitors (0 registered, 135 guests [including 18 identified bots]).
Forum time: 04:40 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5